Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
mi
from
St. Paul, MN
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
St. Paul, MN
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
mi
from
St. Louis, MO
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
mi
from
Las Vegas, NV
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
mi
from
Albany, NY
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Albany, NY
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
mi
from
Tabor City, NC
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Tabor City, NC
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
mi
from
Fargo, ND
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Fargo, ND
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
mi
from
Oklahoma City, OK
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
mi
from
Warwick, RI
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Warwick, RI
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
mi
from
Burlington, VT
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Burlington, VT
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
mi
from
Camperdown,
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Camperdown,
Click here to add this to my saved trials
Brain Training to Enhance Frontal Lobe Reasoning
Brain Training to Enhance Frontal Lobe Reasoning in Soldiers and Civilian Adults With TBI
Status: Enrolling
Updated:  10/24/2016
mi
from
Dallas, TX
Brain Training to Enhance Frontal Lobe Reasoning
Brain Training to Enhance Frontal Lobe Reasoning in Soldiers and Civilian Adults With TBI
Status: Enrolling
Updated: 10/24/2016
Center for BrainHealth
mi
from
Dallas, TX
Click here to add this to my saved trials
On Track: Monitoring Development of Children With Cerebral Palsy or Gross Motor Delay
Developmental Trajectories of Impairments, Health, and Participation of Children With Cerebral Palsy
Status: Enrolling
Updated:  10/25/2016
mi
from
Atlanta, GA
On Track: Monitoring Development of Children With Cerebral Palsy or Gross Motor Delay
Developmental Trajectories of Impairments, Health, and Participation of Children With Cerebral Palsy
Status: Enrolling
Updated: 10/25/2016
Mercer University
mi
from
Atlanta, GA
Click here to add this to my saved trials
On Track: Monitoring Development of Children With Cerebral Palsy or Gross Motor Delay
Developmental Trajectories of Impairments, Health, and Participation of Children With Cerebral Palsy
Status: Enrolling
Updated:  10/25/2016
mi
from
Oklahoma City, OK
On Track: Monitoring Development of Children With Cerebral Palsy or Gross Motor Delay
Developmental Trajectories of Impairments, Health, and Participation of Children With Cerebral Palsy
Status: Enrolling
Updated: 10/25/2016
University of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
On Track: Monitoring Development of Children With Cerebral Palsy or Gross Motor Delay
Developmental Trajectories of Impairments, Health, and Participation of Children With Cerebral Palsy
Status: Enrolling
Updated:  10/25/2016
mi
from
Philadelphia, PA
On Track: Monitoring Development of Children With Cerebral Palsy or Gross Motor Delay
Developmental Trajectories of Impairments, Health, and Participation of Children With Cerebral Palsy
Status: Enrolling
Updated: 10/25/2016
Drexel University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
On Track: Monitoring Development of Children With Cerebral Palsy or Gross Motor Delay
Developmental Trajectories of Impairments, Health, and Participation of Children With Cerebral Palsy
Status: Enrolling
Updated:  10/25/2016
mi
from
Seattle, WA
On Track: Monitoring Development of Children With Cerebral Palsy or Gross Motor Delay
Developmental Trajectories of Impairments, Health, and Participation of Children With Cerebral Palsy
Status: Enrolling
Updated: 10/25/2016
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
On Track: Monitoring Development of Children With Cerebral Palsy or Gross Motor Delay
Developmental Trajectories of Impairments, Health, and Participation of Children With Cerebral Palsy
Status: Enrolling
Updated:  10/25/2016
mi
from
London,
On Track: Monitoring Development of Children With Cerebral Palsy or Gross Motor Delay
Developmental Trajectories of Impairments, Health, and Participation of Children With Cerebral Palsy
Status: Enrolling
Updated: 10/25/2016
University of Western Ontario
mi
from
London,
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Alabaster, AL
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Alabaster, AL
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Jasper, AL
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Jasper, AL
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Mesa, AZ
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Mesa, AZ
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Phoenix, AZ
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Sun City, AZ
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Sun City, AZ
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Laguna Hills, CA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Northridge, CA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Northridge, CA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Oxnard, CA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Oxnard, CA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Pasadena, CA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Pasadena, CA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Redondo Beach, CA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Redondo Beach, CA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Reseda, CA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Reseda, CA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
San Diego, CA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Santa Monica, CA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Colorado Springs, CO
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Denver, CO
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Denver, CO
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Wheat Ridge, CO
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Boca Raton, FL
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Largo, FL
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Largo, FL
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
St. Petersburg, FL
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Stuart, FL
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Stuart, FL
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Tampa, FL
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Atlanta, GA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Austell, GA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Austell, GA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Dawsonville, GA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Dawsonville, GA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Macon, GA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Macon, GA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Woodstock, GA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Woodstock, GA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Oak Brook, IL
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Oak Brook, IL
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Lenexa, KA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Lenexa, KA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Topeka, KA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Topeka, KA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Baton Rouge, LA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Springfield, MA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Springfield, MA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Bingham Farms, MI
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Bingham Farms, MI
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Las Vegas, NV
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
mi
from
Cherry Hill, NJ
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials